This global platform will focus on emerging trends in cancer diagnostics, therapeutic advancements, immuno-oncology breakthroughs, and translational medicine. Participants will gain insights into the latest research developments on CAR-T cell therapy, cancer vaccines, immune checkpoint inhibitors, tumor microenvironment, and biomarker discovery.